symptomaticobstructivehcmrx.com domain details, CAMZYOS™ (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment
Description: CAMZYOS™ is a treatment option for adult patients with symptomatic Class II-III obstructive hypertrophic cardiomyopathy (HCM). See full Prescribing Info for BOXED WARNING and REMS.
Domain rank: 100000000
Domain speed: Fast (0.148 seconds at 0.642 MB/s)
Indexed URLs from symptomaticobstructivehcmrx.com website (11)
The links in column here only counts links from external domains.
found date
links in
url title
url
2022-07-21
CAMZYOS™ (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment
2022-07-21
symptomaticobstructivehcmrx.com/content/commercial/us/camzyoshcp/en/efficacy/secondary-endpoints.html#nyha-class-2
2022-07-21
CAMZYOS™ (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment
symptomaticobstructivehcmrx.com/content/commercial/us/camzyoshcp/en/efficacy/secondary-endpoints.htm#lvot-obstruction-0
2022-07-21
CAMZYOS™ (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment
symptomaticobstructivehcmrx.com/content/commercial/us/camzyoshcp/en/efficacy/secondary-endpoints.html#cardiac-biomarkers-4
2022-07-21
CAMZYOS™ (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment
2022-07-21
CAMZYOS™ (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment
2022-07-21
CAMZYOS® (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment
symptomaticobstructivehcmrx.com/content/commercial/us/camzyoshcp/en/efficacy/secondary-endpoints.html#patient-reported-outcomes- ...
2022-07-21
CAMZYOS® (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment
2022-07-21
CAMZYOS™ (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment
2022-07-27
CAMZYOS® (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment
2022-07-21
CAMZYOS™ (mavacamten) | Symptomatic Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) Treatment